Clinical Trials for Clover Biopharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Clover Biopharmaceuticals

Clinical Trials (3)

NCT06984094
First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
PHASE1Recruiting
192 participants
Started: Jun 18, 2025 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06843317
Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
PHASE1Recruiting
160 participants
Started: Mar 21, 2025 · Completed: Jun 3, 2026
1 condition1 sponsor5 locations
NCT05426369
A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)
PHASE1Active, not recruiting
36 participants
Started: Jun 14, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location